|
|
||||||||
1-integrin signaling and inflammatory responses in airway epithelial cells
Departments of 1Medicine, 2Laboratory Medicine and Pathology, and 3Physiology, University of Alberta, Edmonton, Alberta, Canada; 4Department of Immunology, Max Planck Institute of Infection Biology, Berlin, Germany; and 5University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Submitted 1 July 2004 ; accepted in final form 12 November 2004
The protein tyrosine kinase Syk is critically involved in immunoreceptor signaling in hematopoietic cells. Recent studies demonstrate Syk expression in nonhematopoietic cells, including fibroblasts, endothelial cells, hepatocytes, and breast epithelium. However, the role of Syk in these cells is uncertain. We hypothesized that Syk is expressed in respiratory epithelial cells (EC) and that it functions as a signaling molecule involved in inflammatory responses in the epithelium. With the use of immunohistochemistry, Western blot, PCR, and laser scanning confocal microscopy, Syk was detected in human, rat, and mouse bronchial epithelium in situ and in cultured human bronchial EC in primary cells and the cell lines HS-24 and BEAS-2B. Syk-dependent signaling pathways in EC were initiated by engagement of
1-integrin receptors. Stimulation of
1-integrin receptors by fibronectin or antibody cross-linking caused redistribution of Syk from a cytoplasmic to plasma membrane localization. In stimulated cells, Syk and
1-integrin colocalized. In addition, following
1-integrin receptor engagement, tyrosine phosphorylation of Syk was observed. Expression of the intercellular adhesion molecule-1 (ICAM-1) and production of IL-6, both important molecules in lung inflammation, was downregulated in EC treated with Syk small interfering RNA or Syk inhibitor piceatannol. We propose that Syk is involved in signaling pathways induced by integrin engagement in airway EC. Syk-mediated signaling regulates IL-6 and ICAM-1 expression and may be important in the pathophysiology of lung inflammation.
integrins; inflammation
This article has been cited by other articles:
![]() |
M. Buchner, S. Fuchs, G. Prinz, D. Pfeifer, K. Bartholome, M. Burger, N. Chevalier, L. Vallat, J. Timmer, J. G. Gribben, et al. Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia Cancer Res., July 1, 2009; 69(13): 5424 - 5432. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, U. Shrikhande, B. M. Alicie, Q. Zhou, and R. L. Geahlen Role of the Protein Tyrosine Kinase Syk in Regulating Cell-Cell Adhesion and Motility in Breast Cancer Cells Mol. Cancer Res., May 1, 2009; 7(5): 634 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Inubushi, M. Nagano-Fujii, K. Kitayama, M. Tanaka, C. An, H. Yokozaki, H. Yamamura, H. Nuriya, M. Kohara, K. Sada, et al. Hepatitis C virus NS5A protein interacts with and negatively regulates the non-receptor protein tyrosine kinase Syk J. Gen. Virol., May 1, 2008; 89(5): 1231 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, E. Devarajan, J. He, S. P. Reddy, and J. L. Dai Transcription Repressor Activity of Spleen Tyrosine Kinase Mediates Breast Tumor Suppression Cancer Res., November 15, 2005; 65(22): 10289 - 10297. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Norsett, A. Laegreid, M. Langaas, S. Worlund, R. Fossmark, H. L. Waldum, and A. K. Sandvik Molecular characterization of rat gastric mucosal response to potent acid inhibition Physiol Genomics, June 16, 2005; 22(1): 24 - 32. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |